Research shows how commercial health plans impact payer trends in the co-pay landscape and provides key areas that pharmaceutical and biotech manufacturers can explore to ensure patient access.
Kathryne Kirk
Advertisement
Kathryne Kirk is a Managing Consultant in the Guidehouse Life Sciences practice.
Articles by Kathryne Kirk
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
2
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
3
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
4
Revumenib Granted FDA Approval for R/R NPM1-Mutated AML
5
